Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Endothelin: a knockout in London

Article Abstract:

New developments in endothelin research were the center of attention during the 4th International Conference on Endothelin from Apr. 23-26, 1995 in the UK. Topics that were presented included gene targeting of the endothelin 1 gene, expression cloning of endothelin converting enzyme (ECE), the development of ECE inhibitors and identification of ECE receptors and its antagonists. The classification and structural model of ECE and the effects of ECE antagonists in relation to diseases as shown in animal models are presented.

Author: Warner, Timothy D., Battistini, Bruno, Botting, Renia
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1995
Research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The Institute of Pharmacology of Sherbrooke: a first in Canada

Article Abstract:

The construction of the Institute of Pharmacology of Sherbrooke (IPS) is expected to be finished in mid-1997. The ISP, which is an expansion of the Dept. of Pharmacology at the University of Sherbrooke, will have three floors and a 100-seat lecture facility for research conferences. A team of medicinal chemists, under the direction of Dr. Pierre Deslonchamps, will develop new drugs at the IPS. Some 250 research and administrative staff will be housed at the IPS' laboratories and offices.

Author: Battistini, Bruno
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Management, Buildings and facilities, University of Sherbrooke, Pharmaceutical research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


California dreamin' 'bout endothelin: emerging new therapeutics

Article Abstract:

Endothelin has been suspected of being responsible for many cardiovascular diseases. Endothelin-1 has been proven to cause malformation of blood vessels in developing mouse embryos, while endothelin-2 action on developing embryos is still unclear but has been shown to cause death at the infancy stage. Research direction is focused on antagonizing cell receptivity to endothelin and in identifying endothelin receptor subtypes.

Author: Warner, Timothy D., Elliott, John D., Ohlstein, Eliot H.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1996
Care and treatment, Cardiovascular diseases, Physiological aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Endothelin
Similar abstracts:
  • Abstracts: Endothelin: new discoveries and rapid progress in the clinic. Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed
  • Abstracts: This and that: creatine's superfluous methyl and the shadowed art of Cimabue. This and that: the fire of Galileo's imagination and putting teeth into toxicology
  • Abstracts: Anaesthetics in a bind? Allosteric modulation of 5-HT3 receptors: focus on alcohols and anaesthetic agents. Recent advances in the electrophysiological characterization of 5-HT3 receptors
  • Abstracts: Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Romancing receptor research at Verona classification meeting
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.